CY1122474T1 - Μεθοδος διαγνωσης νευραλγιας του τριδυμου - Google Patents

Μεθοδος διαγνωσης νευραλγιας του τριδυμου

Info

Publication number
CY1122474T1
CY1122474T1 CY20191101277T CY191101277T CY1122474T1 CY 1122474 T1 CY1122474 T1 CY 1122474T1 CY 20191101277 T CY20191101277 T CY 20191101277T CY 191101277 T CY191101277 T CY 191101277T CY 1122474 T1 CY1122474 T1 CY 1122474T1
Authority
CY
Cyprus
Prior art keywords
trigemic
neuralgy
diagnosis
diagnosing
respond
Prior art date
Application number
CY20191101277T
Other languages
English (en)
Inventor
Valerie MORISSET
Original Assignee
Convergence Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Convergence Pharmaceuticals Limited filed Critical Convergence Pharmaceuticals Limited
Publication of CY1122474T1 publication Critical patent/CY1122474T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Control Of Eletrric Generators (AREA)
  • Control Of Turbines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Η εφεύρεση αφορά μία μέθοδο διάγνωσης διαταραχής παροξυσμικού πόνου, όπως η νευραλγία του τριδύμου, σε ένα ανθρώπινο υποκείμενο και επίσης παρέχει μία μέθοδο ταυτοποίησης ασθενών που είναι πλέον πιθανόν να αποκριθούν στη θεραπεία και σε κιτ για χρήση στις εν λόγω μεθόδους.
CY20191101277T 2014-06-03 2019-12-04 Μεθοδος διαγνωσης νευραλγιας του τριδυμου CY1122474T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1409851.1A GB201409851D0 (en) 2014-06-03 2014-06-03 Diagnostic method
PCT/GB2015/051618 WO2015185924A1 (en) 2014-06-03 2015-06-03 Diagnostic method

Publications (1)

Publication Number Publication Date
CY1122474T1 true CY1122474T1 (el) 2021-01-27

Family

ID=51214656

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191101277T CY1122474T1 (el) 2014-06-03 2019-12-04 Μεθοδος διαγνωσης νευραλγιας του τριδυμου

Country Status (14)

Country Link
US (2) US20170096708A1 (el)
EP (1) EP3152325B1 (el)
CY (1) CY1122474T1 (el)
DK (1) DK3152325T3 (el)
ES (1) ES2754281T3 (el)
GB (1) GB201409851D0 (el)
HR (1) HRP20191727T1 (el)
HU (1) HUE046721T2 (el)
LT (1) LT3152325T (el)
PL (1) PL3152325T3 (el)
PT (1) PT3152325T (el)
RS (1) RS59481B1 (el)
SI (1) SI3152325T1 (el)
WO (1) WO2015185924A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201417497D0 (en) * 2014-10-03 2014-11-19 Convergence Pharmaceuticals Novel use
AU2017353841A1 (en) * 2016-11-02 2019-05-30 Biogen Ma Inc. Novel dosage regimen
BR112020021101A2 (pt) * 2018-04-16 2021-02-23 Biogen Ma Inc métodos de tratamento da dor neuropática
CN110982891B (zh) 2019-12-23 2022-03-11 四川省人民医院 一种阵发性室上性心动过速的筛查试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE349551T1 (de) * 2000-07-11 2007-01-15 Kirk Hogan Verfahren und zusammensetzungen zur bestimmung von perioperativen genomprofile
US20130296182A1 (en) * 2010-08-31 2013-11-07 Andrew P. Feinberg Variability single nucleotide polymorphisms linking stochastic epigenetic variation and common disease

Also Published As

Publication number Publication date
US20220098664A1 (en) 2022-03-31
US20170096708A1 (en) 2017-04-06
EP3152325A1 (en) 2017-04-12
SI3152325T1 (sl) 2020-02-28
PL3152325T3 (pl) 2020-03-31
HRP20191727T1 (hr) 2020-01-24
ES2754281T3 (es) 2020-04-16
PT3152325T (pt) 2019-10-14
GB201409851D0 (en) 2014-07-16
DK3152325T3 (da) 2019-10-07
WO2015185924A1 (en) 2015-12-10
RS59481B1 (sr) 2019-12-31
EP3152325B1 (en) 2019-09-04
LT3152325T (lt) 2019-10-10
HUE046721T2 (hu) 2020-03-30

Similar Documents

Publication Publication Date Title
EA201792642A1 (ru) Способы диагностики для т-клеточной терапии
CY1122474T1 (el) Μεθοδος διαγνωσης νευραλγιας του τριδυμου
CY1123746T1 (el) Ανθρωποποιημενα tau αντισωματα σε νοσο του alzheimer
CY1120177T1 (el) Φλαγκελλινη roseburia και ανοσορυθμιση
CY1123067T1 (el) Μεθοδοι αγωγης ασθενων καρκινων με αναστολεις τρανσφερασης φαρνεσυλιου
SV2018005677A (es) Mutaciones puntuales en cancer resistente a trk y metodos relacionados con las mismas
EA201591417A1 (ru) Новый способ диагностики депрессии и мониторинга эффективности терапии
CL2017002781A1 (es) Métodos de tratamiento de enfermedad de alzheimer
EA201691607A1 (ru) Микроорганоиды и способы их получения и применения
EA201691314A1 (ru) Терапевтические способы и композиции
EA201990778A1 (ru) Анти-il-33 антитела и их применение
BR112014018592A2 (pt) composição e método para o diagnóstico e tratamento de doenças associadas à degeneração de neuritos
BR112015021423A2 (pt) métodos de tratamento de câncer, de células de câncer e de câncer resistente a antagonista de egfr, métodos de aumento da sensibilidade e da eficácia de tratamento de câncer e métodos de atraso, de tratamento de indivíduos com câncer e de extensão
CY1123216T1 (el) Αναστολεις της gls1 για την αντιμετωπιση νοσων
CY1122615T1 (el) Θεραπεια με βλαστοκυτταρα σε παθολογιες τουενδομητριου
EA201691887A1 (ru) Лечение внутрипеченочных холестатических заболеваний
GB2561300B (en) Method and system for diagnosing disease and generating treatment recommendations
EA201790444A1 (ru) Hsp90-направленная визуализация и терапия воспаления и инфекции
MX2021003764A (es) Determinacion de trastornos de la motilidad de los intestinos y la vejiga, y de la fibromialgia.
EA201890347A1 (ru) Антитела и исследования для обнаружения cd37
BR112018014762A2 (pt) método de tratamento da doença de alzheimer (da) precoce
CY1117588T1 (el) Μεθοδος βιολογικης καταπολεμησης εναντιον των ψευδομοναδων
CY1121957T1 (el) Χρηση της αδελμιδρολης στη θεραπεια επιθηλιακων δυσλειτουργιων
MY185990A (en) Marker for acid sphingomyelinase disorders and uses thereof
EA202090260A1 (ru) Средства и способы для генотерапии aav у человека